百佳乐官方网站-百佳乐手机版下载

“Popularization of Drug Safety Science Benefits the People” The Launching Ceremony and the Open to Public Day of the 2019 “Drug Science and Technology Week” Activity Were Held in Beijing

2019/5/24 14:09:20 source:Science and Technology Development Center of CPA Author: Print
On May 21, the launching ceremony and the Open to Public Day activity of the 2019 “Drug Science and Technology Week” sponsored by National Medical Products Administration (NMPA) and undertaken by National Institutes for Food and Drug Control (NIFDC) and Chinese Pharmaceutical Association (CPA) were held in NIFDC. The “Popularization of Drug Safety Science Benefits the People” - themed activity is one of a series of activities in the Science and Technology Week sponsored by NMPA. Li Bo, Party Committee Secretary and Director General of NIFDC and Vice President of CPA presided over the launching ceremony. Xu Jinghe, Deputy Director of NMPA, Sun Xianze, Deputy Director of Subcommittee of Education, Science, Culture, Health and Sports of the 13th CPPCC and President of CPA, Mao Zhenbin, Inspector of Department of Science, Technology and International Cooperation (Office of Hong Kong, Macao and Taiwan Affairs) (DSTIC) and Zhou Naiyuan, Head of Science and Technology Division of DSTIC, NMPA, Ding Lixia, Vice President and Secretary-General of CPA, Lu Yong, Deputy Director of NIFDC, Tian Dexiang, the Secretary of the Working Committee and Director of Management Committee of Daxing Bio-Pharmaceutical Industry Base at Zhongguancun Science and Technology Park attended the activity. 100 representatives from various circles such as pharmaceutical enterprise delegates from Daxing Bio-Pharmaceutical Industry Base, college students from Peking University School of Pharmaceutical Science as popular science volunteers and news reporters from more than 10 media groups participated in the activity. 
 
At the launching ceremony, Xu Jinghe said that carrying out the drug safety science and technology activities is an important part of implementing the people-centered development concept, promoting the public to better understand the relationship between scientific and technological innovation and drug safety, and improving the scientific literacy and health conditions of the whole people. The Drug Science and Technology Week activity was organized with the following objectives. 1) We should further popularize drug knowledge as this is our regulatory responsibility that needed to be shouldered conscientiously. "Protecting and promoting public health" is the shared mission of drug regulatory authorities and all drug stakeholders in the new era. It is necessary to deeply popularize the knowledge of drug science and technology, and create an active atmosphere in which everyone concerns, supports and participates in drug science and technology innovation and ensures drug safety. 2) We should popularize drug knowledge in all respects focusing on the theme of drug safety. Centering on the five themes including “Innovation, Quality, Efficiency, System and Capability”, the innovation achievements of drugs and medical devices gained in recent years were fully displayed. The sense of well-being, happiness and sense of security among the public would be further enhanced through building consensus with innovation, demonstrating ability and showing image. 3) We will insist on the joint-governance for drug safety in order to give wide publicity to the drug safety knowledge. Ensuring drug safety is the common responsibility of all people. It is essential to extensively popularize drug safety knowledge in order to build the long-term pattern of drug safety joint-governance in which enterprises are responsible, government plays the role of regulator, industry remains self-disciplined, the whole society works coordinately, the public actively participate in, the media act as supervisor and the law brings into security. 4) We will advance the drug regulatory science to popularize drug knowledge continually. The NMPA has initiated China’s Drug Regulatory Science Action Plan and identified the first nine key research projects. The next step is to further rev up publicity and to make more experts participate in regulatory science research, thereby continuously improving the level of scientific, legalized, internationalized and modernized drug regulation in China.
 
Sun Xianze indicated that with the deepening reform of medical and health system in China, the public has an increasingly urgent need to understand disease and medication knowledge. Popularization of drug safety science is an important measure to benefit all the people. I hope that all the pharmaceutical science and technology workers will actively participate in the work of popular science, continue to deliver a stable performance in the dissemination and popularization of drug safety knowledge, in order to contribute to ensuring the medication safety and health of all the people and to celebrating the 70th anniversary of the founding of the People's Republic of China.
 
In the activity, Zhu Kangqin, Chief Expert for policy research of Science and Technology Development Center of CPA and Hu Songnian, Director of Key Laboratory of Genome Sciences & Information, Beijing Institute of Genomics, Chinese Academy of Sciences gave lectures entitled "Thoughts on the Development and Reform of Chinese Pharmaceutical Industry" and "Pharmacogenomics Guiding Individualization of Dosage” respectively.
 
Focusing on the "Five Stimulus” driving the development and reform of pharmaceutical industry, Zhu Kangqin expounded that accelerating the transformation of major scientific & technological achievements to practical productive forces is causing a global industry reform. It is required that China's pharmaceutical enterprises should participate in reshaping the value chain actively, instead of being passively involved in the global value chain assignments as they used to do. Starting from the active participation, China's pharmaceutical enterprises will become into leaderships.
 
Taking hypertension, diabetes and other complex chronic diseases as examples, Hu Songnian introduced the guidance of pharmacogenomics on precise and individualized dosage systematically. With the development of high-throughput sequencing technology and individualized and precision medicine, "Genome-based Drug Response Potential" is expected to gradually develop into one of the indicators of clinical diagnosis.
 
After the launching ceremony, the representatives visited the Laboratory of the Institute for Chemical Drug Control, NIFDC. The laboratory staff made a detailed introduction for the Laboratory conditions, instruments and devices, control and testing procedures, and patiently and carefully answered the questions raised by everyone.
 
"Science and Technology Week" is a nationwide public science and technology activity established by the State Council. Since 2001, the Ministry of Science and Technology of the People's Republic of China, the Publicity Department of the Central Committee of the CPC and the China Association for Science and Technology have jointly organized the "Science and Technology Week" in the third week of May every year. Since 2015, the NMPA has been also holding the Science and Technology Week for National Drug Regulatory System during the same period every year, displaying the drug science and technology innovation achievements that are closely related to people's life, highlighting the level of drug science and technology innovation and the development of popular science, and strengthening the popularization and education of drug safety knowledge. According to incomplete statistics, from 2015 to 2018, the "Science and Technology Week" covered 31 provinces (autonomous regions, municipalities) and Xinjiang Production and Construction Corps, with 22,000 participating units and public coverage of more than 18.8 million people, achieving excellent results.
 
The 2019 Drug Science and Technology Week highlights the theme of "Popularization of Drug Safety Science Benefits the People", which will last one week. A number of thematic publicity activities will be held, including the Open to Public Day, "Scientific Medication and Popularization of the Poverty Alleviation Science" and "Sail Your Dream with Science", the science popularization public service in campus. Various forms of publicity activities surrounding the themes will be also be conducted around our country.
 
Xu Jinghe, Deputy Director of NMPA Delivers a Speech
 
Sun Xianze, Deputy Director of Subcommittee of Education, Science, Culture, Health and Sports of the 13th CPPCC National Committee and Director of CPA Delivers a Speech
 
Li Bo, Director and Party Committee Secretary General of NIFDC and Vice President of CPA Presides over the Activity
 
Zhu Kangqin, Chief Expert for Policy Research of Science and Technology Development Center of CPA Makes a Special Report
 
Hu Songnian, Director of Key Laboratory of Genome Sciences & Information, Beijing Institute of Genomics, Chinese Academy of Sciences Makes a Special Report
 
The Launching Ceremony and the Open to Public Day Activity of the 2019 “Drug Science and Technology Week” 
 
The Representatives Visit the Laboratory of the Institute for Chemical Drug Control, NIFDC.
 
 
 

Government agencyLocal learningHospital websiteIndustry media

WORLD HEALTH ORGANIZATION CHINA ASSOCIATION FOR SCIENCE AND TECHNOLOGY DEVELOPMENT RESEARCH CENTER OF THE STATE COUNCIL OF THE PEOPLE'S REPUBLIC OF CHINA CHINESE ACADEMY OF ENGINEERING CHINESE SOCIAL SCIENCES NET CHINESE ACADEMY OF SCIENCES NATIONAL HEALTH COMMISSION OF THE PEOPLE'S REPUBLIC OF CHINA THE STATE COUNCIL OF THE PEOPLE'S REPUBLIC OF CHINA MINISTRY OF SCIENCE AND TECHNOLOGY OF THE PEOPLE'S REPUBLIC OF CHINA MINISTRY OF COMMERCE OF THE PEOPLE'S REPUBLIC OF CHINA
GANSU PHARMACEUTICAL ASSOCIATION NINGXIA HUI AOTONOMOUS REGION PHARMACEUTICAL SOCIETY SICHUAN PHARMACEUTICAL ASSOCIATION GUANGDONG PHARMACEUTICAL ASSOCIATION SHANDONG PHARMACEUTICAL ASSOCIATION ZHEJIANG PHARMACEUTICAL ASSOCIATION BEIJING PHARMACEUTICAL ASSOCIATION HEBEI PHARMACEUTICAL ASSOCIATION
BEIJING FRIENDSHIP HOSPITAL, CAPITAL MEDICAL UNIVERSITY CHINA-JAPAN FRIENDSHIP HOSPITAL BEIJING HOSPITAL BEIJING TONGREN HOSPITAL, CMU BEIJING JISHUITAN HOSPITAL BEIJING ANZHEN HOSPITAL, CAPITAL MEDICAL UNIVERSITY BEIJING CHAO-YANG HOSPITAL BEIJING TIAN TAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY BEIJING DITAN HOSPITAL CAPITAL MEDICAL UNIVERSITY XUANWU HOSPITAL CAPITAL MEDICAL UNIVERSITY BEIJING SHIJITAN HOSPITAL BEIJING YOUAN HOSPITAL BEIJING OBSTETRICS AND GYNECOLOGY HOSPITAL BEIJING CHILDREN'S HOSPITAL CAPITAL INSTITUTE OF PEDIATRICS CHINESE PLA GENERAL HOSPITAL
MEDICINE.CHINA.COM.CN HEALTH.SOHU.COM JIANKANGBAO XINHUANET EN.PEOPLE.CN
XML 地图 | Sitemap 地图